Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and Pharmacodynamic Study of IV Aspirin (Rho-11) vs Oral Aspirin in Healthy Adults
NCT05166096Phase 1Completed
- Sponsor
- Rhoshan Pharmaceuticals
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lysine acetylsalicylate in thrombosis (2 arms), sponsored by Rhoshan Pharmaceuticals. Primary endpoint: Change in serum thromboxane B2 from baseline at 180 minutes. Started Dec 2021; status: completed.
02
Drugs
lysine acetylsalicylate
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT05166096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05166096.